289 related articles for article (PubMed ID: 31238605)
1. [Progress and challenges in achieving the WHO goal on 'Elimination of Hepatitis B by 2030' in China].
Liu J; Liu M
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Jun; 40(6):605-609. PubMed ID: 31238605
[TBL] [Abstract][Full Text] [Related]
2. Countdown to 2030: eliminating hepatitis B disease, China.
Liu J; Liang W; Jing W; Liu M
Bull World Health Organ; 2019 Mar; 97(3):230-238. PubMed ID: 30992636
[TBL] [Abstract][Full Text] [Related]
3. Requirements for global elimination of hepatitis B: a modelling study.
Nayagam S; Thursz M; Sicuri E; Conteh L; Wiktor S; Low-Beer D; Hallett TB
Lancet Infect Dis; 2016 Dec; 16(12):1399-1408. PubMed ID: 27638356
[TBL] [Abstract][Full Text] [Related]
4. [Promoting hepatitis B elimination and laying emphasis on its economics evaluation].
Zhang SX
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):841-844. PubMed ID: 28738453
[TBL] [Abstract][Full Text] [Related]
5. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china.
Zhao S; Xu Z; Lu Y
Int J Epidemiol; 2000 Aug; 29(4):744-52. PubMed ID: 10922354
[TBL] [Abstract][Full Text] [Related]
6. Current advances in the elimination of hepatitis B in China by 2030.
Zhang S; Wang F; Zhang Z
Front Med; 2017 Dec; 11(4):490-501. PubMed ID: 29170919
[TBL] [Abstract][Full Text] [Related]
7. Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period.
Luo Z; Li L; Ruan B
Int J Infect Dis; 2012 Feb; 16(2):e82-8. PubMed ID: 22178658
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus infection: epidemiology and vaccination.
Shepard CW; Simard EP; Finelli L; Fiore AE; Bell BP
Epidemiol Rev; 2006; 28():112-25. PubMed ID: 16754644
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of hepatitis B and hepatitis B virus infection in United States children.
Shepard CW; Finelli L; Fiore AE; Bell BP
Pediatr Infect Dis J; 2005 Sep; 24(9):755-60. PubMed ID: 16148839
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B vaccination and prevention of hepatocellular carcinoma.
Kao JH
Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):907-17. PubMed ID: 26651252
[TBL] [Abstract][Full Text] [Related]
11. Significant reduction in notification and seroprevalence rates of hepatitis B virus infection among the population of Zhejiang Province, China, aged between 1 and 29years from 2006 to 2014.
Zhou Y; He H; Deng X; Yan R; Tang X; Xie S; Yao J
Vaccine; 2017 Aug; 35(34):4355-4361. PubMed ID: 28687404
[TBL] [Abstract][Full Text] [Related]
12. Moving towards hepatitis B elimination in Gulf Health Council states: From commitment to action.
Al Awaidy ST; Ezzikouri S
J Infect Public Health; 2020 Feb; 13(2):221-227. PubMed ID: 31445879
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B Virus Infection and the Progress toward its Elimination.
Hsu HY; Chang MH
J Pediatr; 2019 Feb; 205():12-20. PubMed ID: 30244984
[No Abstract] [Full Text] [Related]
14. Epidemiology and prevention of hepatitis B virus infection in China.
Lu FM; Li T; Liu S; Zhuang H
J Viral Hepat; 2010 Mar; 17 Suppl 1():4-9. PubMed ID: 20586928
[TBL] [Abstract][Full Text] [Related]
15. Progress in the prevention and control of viral hepatitis type B: closing remarks.
Rizzetto M; Zanetti AR
J Med Virol; 2002 Jul; 67(3):463-6. PubMed ID: 12116047
[TBL] [Abstract][Full Text] [Related]
16. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B vaccination in Iran: Historical policies and programs.
Behzadifar M; Azari S; Shirkhani S; Gholamrezaei S; Shahabi S; Doshmangir L; Ehsanzadeh SJ; Martini M; Bragazzi NL; Behzadifar M
J Prev Med Hyg; 2022 Dec; 63(4):E618-E624. PubMed ID: 36891002
[TBL] [Abstract][Full Text] [Related]
18. Strategy vaccination against Hepatitis B in China.
Liao X; Liang Z
Hum Vaccin Immunother; 2015; 11(6):1534-9. PubMed ID: 25881006
[TBL] [Abstract][Full Text] [Related]
19. [Development of Markov models for economics evaluation of strategies on hepatitis B vaccination and population-based antiviral treatment in China].
Yang PC; Zhang SX; Sun PP; Cai YL; Lin Y; Zou YH
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):845-851. PubMed ID: 28738454
[No Abstract] [Full Text] [Related]
20. [China's hepatitis B burden and expectation on 40 years of trials and tribulations].
Cai DC; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):3-5. PubMed ID: 30685915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
